Phio Pharmaceuticals Corp. (PHIO)

1.08 -0.03 (-2.70%) USD  |  NASDAQ  |  Sep 04, 16:00
1.08 0.00 (0.00%) After-Hours: 20:00
More

Phio Pharmaceuticals SG&A Expense (TTM) : 4.941M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for PHIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 4.941M
March 31, 2026 4.99M
December 31, 2025 4.602M
September 30, 2025 4.234M
June 30, 2025 3.856M
March 31, 2025 3.669M
December 31, 2024 3.744M
September 30, 2024 3.821M
June 30, 2024 3.843M
March 31, 2024 3.959M
December 31, 2023 4.366M
September 30, 2023 4.716M
June 30, 2023 4.811M
March 31, 2023 4.864M
December 31, 2022 4.45M
September 30, 2022 4.989M
June 30, 2022 4.858M
March 31, 2022 4.662M
December 31, 2021 4.625M
September 30, 2021 4.254M
June 30, 2021 4.372M
March 31, 2021 4.241M
December 31, 2020 4.362M
September 30, 2020 4.724M
June 30, 2020 4.745M
Date Value
March 31, 2020 4.768M
December 31, 2019 4.708M
September 30, 2019 3.852M
June 30, 2019 3.492M
March 31, 2019 3.353M
December 31, 2018 3.176M
September 30, 2018 3.188M
June 30, 2018 3.463M
March 31, 2018 3.789M
December 31, 2017 4.011M
September 30, 2017 4.241M
June 30, 2017 4.007M
March 31, 2017 3.792M
December 31, 2016 3.619M
September 30, 2016 3.486M
June 30, 2016 3.504M
March 31, 2016 3.423M
December 31, 2015 3.346M
September 30, 2015 3.205M
June 30, 2015 3.201M
March 31, 2015 3.247M
December 31, 2014 3.217M
September 30, 2014 3.568M
June 30, 2014 3.736M
March 31, 2014 3.863M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Imunon, Inc. 6.645M
Agenus, Inc. 38.48M
Amgen, Inc. 7.019B
Anika Therapeutics, Inc. 52.67M
BioCryst Pharmaceuticals, Inc. 328.11M